Semaglutide sustains lower calorie intake for more than a year, study shows

People taking semaglutide for value nonaccomplishment continued to devour importantly less calories aft 60 weeks connected the medication, helping explicate however the medicine supports some archetypal value nonaccomplishment and semipermanent value maintenance. The study, published successful the American Journal of Clinical Nutrition and led by investigators from Penn's Center for Weight and Eating Disorders and Penn Metabolic Medicine, is among the archetypal to analyse the semipermanent effects of semaglutide connected eating behaviour beyond the archetypal months of treatment.